Medical News Today: Diabetes: Could targeting this protein prevent hypoglycemia?

Could targeting the protein neuronostatin prevent or treat dangerous low blood sugar in people with diabetes who use insulin? A new study investigates.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Diabetes Source Type: news

Related Links:

Publication date: Available online 16 July 2019Source: Journal of Contextual Behavioral ScienceAuthor(s): Kitty Kioskli, Kirsty Winkley, Lance M. McCrackenAbstractPainful diabetic neuropathy (PDN) is a distressing and disabling condition. There is, surprisingly, relatively little research into the role of psychological variables related to PDN. The aim of this study was to investigate the association between psychological flexibility, daily functioning, and distress in people with PDN. This cross-sectional study included 225 participants who were recruited from hospital services and online. In correlation analyses, accepta...
Source: Journal of Contextual Behavioral Science - Category: Psychiatry & Psychology Source Type: research
Ratiometric fluorescence monitoring of α-glucosidase activity based on oxidase-like property of MnO2 nanosheet and its application for inhibitor screening. Anal Chim Acta. 2019 Oct 24;1077:225-231 Authors: Shi M, Cen Y, Xu G, Wei F, Xu X, Cheng X, Chai Y, Sohail M, Hu Q Abstract In recent years, α-glucosidase (α-Glu) inhibitor has been widely used in clinic for diabetic and HIV therapy. Although different systems have been constructed for sensitive and selective detection of α-Glu and screening its inhibitor, the method based on ratiometric fluorescence for α-glucosidase ...
Source: Analytica Chimica Acta - Category: Chemistry Authors: Tags: Anal Chim Acta Source Type: research
Publication date: September 2019Source: Journal of Functional Foods, Volume 60Author(s): Maria Cermeño, Alan Connolly, Martina B. O'Keeffe, Cal Flynn, Adeola M. Alashi, Rotimi E. Aluko, Richard J. FitzGeraldAbstractBrewer's spent grain (BSG) is a co-product of the brewing industry and is a potentially rich source of bioactive peptides. A BSG protein hydrolysate, manufactured at a semi-pilot scale, mediated significant hypotensive effects 6 h after ingestion in spontaneously hypertensive rats. This hydrolysate was fractionated and further analysed by UPLC-ESI-MS/MS for peptide identification. The peptides, IPY and ...
Source: Journal of Functional Foods - Category: Nutrition Source Type: research
Publication date: September 2019Source: Journal of Functional Foods, Volume 60Author(s): Jingwen Xu, Sriram K. Vidyarthi, Weibin Bai, Zhongli PanAbstractRosa roxburghii (R. roxburghii), primarily distributed in southwest region in China, is known for its remarkable high vitamin C, SOD, and flavonoids contents. A diet rich in beneficial antioxidants such as polysaccharides, vitamin C, superoxide dismutase (SOD), and phenolics is associated with reducing risks of chronic diseases. This review examines the chemical composition in fruit of R. roxburghii and their functional properties. Recent studies showed the inhibitory effe...
Source: Journal of Functional Foods - Category: Nutrition Source Type: research
Senseonics Holdings Inc. is looking to raise more than $100 million through two offerings. The Germantown company, with an implantable glucose monitor for patients with diabetes, has initiated an $80 million convertible note offering and another $25 million public offering of common stock, announced Tuesday. For the convertible note, with an aggregate principal amount of 5.25%, a conve rsion rate and other terms will be determined at the point of the offering, according to public filings. That funding…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Publication date: August 2019Source: The Lancet Diabetes &Endocrinology, Volume 7, Issue 8Author(s): Wan Li, Wei Ling, Yi Sui, Hai-Lu Zhao
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research
Publication date: August 2019Source: The Lancet Diabetes &Endocrinology, Volume 7, Issue 8Author(s): Robert A Hegele
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research
Publication date: August 2019Source: The Lancet Diabetes &Endocrinology, Volume 7, Issue 8Author(s):
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research
Publication date: August 2019Source: The Lancet Diabetes &Endocrinology, Volume 7, Issue 8Author(s):
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research
Publication date: August 2019Source: The Lancet Diabetes &Endocrinology, Volume 7, Issue 8Author(s):
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research
More News: Brain | Diabetes | Endocrinology | Health | Insulin | Neurology | Study | Sugar